Capsular Polysaccharide and Conjugate Vaccines

This publication has 15 references indexed in Scilit:

• Immunisation of infants in Iceland against Haemophilus influenzae type b
  The Lancet, 1992
• High Antibody Responses to Booster Doses of Either Haemophilus influenzae CapsularPolysaccharide or Conjugate Vaccine after Primary Immunization with Conjugate Vaccines
  The Journal of Infectious Diseases, 1992
• The Efficacy in Navajo Infants of a Conjugate Vaccine Consisting ofHaemophilus influenzaeType b Polysaccharide andNeisseria meningitidisOuter-Membrane Protein Complex
  New England Journal of Medicine, 1991
• Protective efficacy of Haemophilus influenzae type b polysaccharide and conjugate vaccines in children 18 months of age and older
  Published by American Medical Association (AMA) ,1991
• Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease
  The Journal of Pediatrics, 1988
• ANTIBODY LEVELS ACHIEVED IN INFANTS BY COURSE OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE/DIPHTHERIA TOXOID CONJUGATE VACCINE
  The Lancet, 1985
• ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS
  The Lancet, 1983
• Meningococcal Disease: Still with Us
  Clinical Infectious Diseases, 1983
• A Study of the Pneumococcal Vaccine in Prevention of Clinically Acute Attacks of Recurrent Otitis Media
  Clinical Infectious Diseases, 1981
• Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.
  The Journal of Experimental Medicine, 1980